Calendar

Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.

Upcoming as of , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.

8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.

Add to your calendar (calendar.ics)

The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.

Upcoming

July 2028 92

  1. Primary completion Randomized Study of Triple Therapy vs Sildenafil Dose Optimization in Pulmonary Arterial Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07713914

  2. Primary completion PulseMagic™ TrueForce™ PAF NMPA Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07720557

  3. Study completion Dutch Intracerebral Hemorrhage Surgery Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05460793

  4. Study completion Effect of Zinc on Glucose Homeostasis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05835037

  5. Primary completion Effect of Zinc on Glucose Homeostasis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05835037

  6. Study completion ASCVD Management Using CCTA in Prostate Cancer Patients on ADT Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05879913

  7. Study completion MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05908331

  8. Primary completion Strategy for Improving Stroke Treatment Response Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05948566

  9. Primary completion Impact GLP-1 Agonists Following Bariatric Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06132477

  10. Primary completion Synchronized Diaphragmatic Stimulation in Symptomatic Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06552637

  11. Study completion Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06822790

  12. Primary completion Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06822790

  13. Study completion Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06911632

  14. Primary completion Postpartum Evaluation of Nifedipine and Enalapril for Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07023003

  15. Primary completion High Flow Nasal Oxygenation in Transcatheter Aortic Valve Replacement Procedures. TAVR-Highflow II Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07059728

  16. Primary completion GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1 Post-Approval Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07166133

  17. Study completion CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07220304

  18. Primary completion Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07314775

  19. Study completion Intravascular Ultrasound Imaging Guidance for Optimal Revascularization of Limb Arteries Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07353905

  20. Primary completion The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07359599

  21. Study completion Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07370688

  22. Primary completion Iron Infusion in Patients Undergoing Transcatheter Aortic Valve Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07370688

  23. Study completion Comparing Two PFO Closure Devices in Adults With Previous Stroke or TIA Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07380490

  24. Primary completion Comparing Two PFO Closure Devices in Adults With Previous Stroke or TIA Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07380490

  25. Primary completion A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07404553

  26. Primary completion A Study of Metformin to Improve Cardiac Function After LVAD Implantation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07666698

  27. Study completion Oral Versus Intravenous Tranexamic Acid in Off-Pump Coronary Artery Bypass Surgery Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07740330

  28. Study completion A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07743450

  29. Primary completion A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07743450

  30. Study completion Smartphone Based-PPG Assessment of REconversion in Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07752940

  31. Study completion Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07920939

  32. Primary completion Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic Pathologies Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04524247

  33. Study completion A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07662109

  34. Primary completion A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07662109

  35. Primary completion Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07189234

  36. Study completion A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07919405

  37. Study completion Neuralert Stroke Monitor Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07362303

  38. Study completion Colchicine Versus Placebo in Acute Myocarditis Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05855746

  39. Study completion COgnitioN With VERiciGuat Evaluation in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06601465

  40. Primary completion COgnitioN With VERiciGuat Evaluation in Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06601465

  41. Primary completion Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07575269

  42. Study completion Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05949008

  43. Primary completion Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06587737

  44. Study completion Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06842147

  45. Primary completion Effectiveness of Artificial IntelliGence-Driven Single-LEad Long-TerM Electrocardiograms MonItoring in Detecting New-Diagnosed Atrial FIbrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06842147

  46. Primary completion Hebbian-Type Associative Stimulation in Stroke Rehabilitation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07085910

  47. Primary completion Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis(ECHO-TAVR) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07317804

  48. Primary completion A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07584967

  49. Study completion Prospective Multi-Center Randomized Study for Evaluating the EVAHEART®2 Left Ventricular Assist System Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01187368

  50. Study completion Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04562805

  51. Study completion Rehabilitation for Survivors of Out-of-hospital Cardiac Arrest Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05173740

  52. Primary completion The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05618353

  53. Study completion DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05701917

  54. Study completion Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06047262

  55. Primary completion Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06047262

  56. Study completion Non-pharmacologial, Non-invassive Intervention Before Cardiac Surgery: a Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06791551

  57. Primary completion Non-pharmacologial, Non-invassive Intervention Before Cardiac Surgery: a Randomized Controlled Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06791551

  58. Study completion Prevention and Treatment for Bruises in Patients With Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06823999

  59. Primary completion Prevention and Treatment for Bruises in Patients With Ischemic Stroke Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06823999

  60. Study completion Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06908473

  61. Primary completion Tongmai Jiangtang Capsule for Cardiovascular Clinical Outcomes in High-Risk Metabolic Syndrome Patients Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06908473

  62. Primary completion Study to Evaluate the Efficacy and Safety of Lerodalcibep in Children 6 to 17 Years, With Heterozygous FH Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07102511

  63. Study completion A Multicenter Randomized Controlled Trial of Echocardiography-Guided Atrial Septal Defect Closure Performed in a Mobile Surgical Unit Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07273227

  64. Study completion Echo-Guided vs Fluoroscopy-Guided Transcatheter Aortic Valve Replacement in Patients With Aortic Stenosis(ECHO-TAVR) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07317804

  65. Study completion Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07734792

  66. Study completion Prophylactic IABP in Delayed-Presentation Anterior STEMI Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07761455

  67. Primary completion Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic Annuli Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07794306

  68. Primary completion Vortosiran in Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07870889

August 2028 63

  1. Study completion Conscious Sedation Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06049615

  2. Study completion The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06606821

  3. Primary completion Phase III Clinical Study on the Efficacy and Safety of Semaglutide and Ozempic® in Patients With Type 2 Diabetes Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07046273

  4. Primary completion Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07441200

  5. Study completion Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07476898

  6. Primary completion Remote Monitoring and Optimization of Heart Failure Therapy Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07622472

  7. Study completion Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01874197

  8. Primary completion Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT01874197

  9. Study completion The JenaValve ALIGN-AR Pivotal Trial Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04415047

  10. Study completion A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05205499

  11. Primary completion The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection Fraction Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05508035

  12. Study completion Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05677100

  13. Primary completion ELEVATE-HFpEF Clinical Study Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06678841

  14. Study completion A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06785116

  15. Primary completion A Randomized, Placebo-controlled Trial of DAPAgliflozin (DAPA) for Cardiovascular Risk Reduction in the Postpartum Period of Hypertensive Pregnancies (HP) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06785116

  16. Study start Early Discharge With Subcutaneous Furosemide Versus Standard Care in Acute Heart Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07018297

  17. Study completion A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07404553

  18. Primary completion Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial Fibrillation Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07575828

  19. Study completion Efficacy of pHA130 Hemoadsorption on Protein-Bound Uremic Toxins and Quality of Life in Kidney Failure Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07656168

  20. Primary completion Aneurysm Treatment Using the Heli-FX™ EndoAnchor™ System China Study(ATHENA) Registry record

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT07754318

Overdue

The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.

  1. Study start Effect of Patient Management Based on Continuous Continuous Glucose Monitoring on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes and Moderate to Severe Coronary Artery Stenosis Registry record

    Expected 2024-01; that period ended on 2024-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06060483

  2. Study start Pulmonary Artery Catheterization and Carvedilol Early Initiation in Cardiogenic SHOCK Due to HFrEF Registry record

    Expected 2024-01; that period ended on 2024-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06078436

  3. Study start Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease Registry record

    Expected 2024-01; that period ended on 2024-01-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06203236

  4. Study completion Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock Registry record

    Expected 2024-02-01; that period ended on 2024-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03813134

  5. Primary completion Paclitaxel-Coated Balloon Versus Zotarolimus-Eluting Stent for Treatment of De Novo Coronary Artery Lesions Registry record

    Expected 2024-02-01; that period ended on 2024-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05209412

  6. Study completion Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair Registry record

    Expected 2024-02-01; that period ended on 2024-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05421130

  7. Primary completion Safety and Efficacy of Evolocumab in Ischemic Stroke Registry record

    Expected 2024-02-01; that period ended on 2024-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05697185

  8. Study start All Women Comparing Self-expanding ALLEGRA Valve to Any Other Balloon-expandable Valve Registry record

    Expected 2024-02-01; that period ended on 2024-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05989074

  9. Study start Role of Eplerenone in Reducing Recurrence of Atrial Fibrillation in Patient With Structural Heart Disease Registry record

    Expected 2024-02-01; that period ended on 2024-02-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06168994

  10. Study start Henagliflozin in Relieving Type 2 Diabetes With Non-alcoholic Fatty Liver Disease Registry record

    Expected 2024-02-15; that period ended on 2024-02-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06218342

  11. Primary completion Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures Registry record

    Expected 2024-02-20; that period ended on 2024-02-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05292846

  12. Primary completion Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related Hypertension Registry record

    Expected 2024-02-24; that period ended on 2024-02-24.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04474899

  13. Study completion Ferumoxytol-enhanced Magnetic Resonance Imaging Registry record

    Expected 2024-02-27; that period ended on 2024-02-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02954510

  14. Study completion Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction Registry record

    Expected 2024-02-28; that period ended on 2024-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04806893

  15. Study completion Development of an Information Board and Mobile Application for the Care of Type 2 Diabetes Registry record

    Expected 2024-02-28; that period ended on 2024-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04974333

  16. Primary completion The Flow Diverter for Treating Patients With Intracranial Aneurysms Registry record

    Expected 2024-02-28; that period ended on 2024-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05060185

  17. Primary completion Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk Registry record

    Expected 2024-02-28; that period ended on 2024-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05240781

  18. Study completion To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin Registry record

    Expected 2024-02-28; that period ended on 2024-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05296044

  19. Study completion GlideSheath Slender® Versus Conventional 6 French Arterial Sheath: Impact on the Distal Radial Artery Occlusion (SMART) Registry record

    Expected 2024-02-28; that period ended on 2024-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05501925

  20. Primary completion GlideSheath Slender® Versus Conventional 6 French Arterial Sheath: Impact on the Distal Radial Artery Occlusion (SMART) Registry record

    Expected 2024-02-28; that period ended on 2024-02-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05501925

  21. Primary completion Safety and Effectiveness of Left Bundle Branch Pacing in Patients With Cardiac Dysfunction and AV Block Registry record

    Expected 2024-02; that period ended on 2024-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05553626

  22. Primary completion Clinical Study of Focal Implant Used for Lower Extremity Post-angioplasty Dissection Registry record

    Expected 2024-02; that period ended on 2024-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05562076

  23. Study completion Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2 Registry record

    Expected 2024-02-29; that period ended on 2024-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05843682

  24. Study start Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus Registry record

    Expected 2024-02; that period ended on 2024-02-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05886088

  25. Primary completion Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia Registry record

    Expected 2024-03-01; that period ended on 2024-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT02928094

  26. Study start Effect of Postoperative Prolonged Sedation With Dexmedetomidine After Successful Reperfusion With EVT on Long-term Prognosis in Patients With AIS (PPDET) Registry record

    Expected 2024-03-01; that period ended on 2024-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04916197

  27. Study completion The Impact of Compound Danshen Dropping Pills (CDDP) on the Post-myocardial Infarction Ventricular Remodeling Registry record

    Expected 2024-03-01; that period ended on 2024-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05000411

  28. Primary completion Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention Registry record

    Expected 2024-03-01; that period ended on 2024-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05241431

  29. Primary completion Medical Monitoring of Older Adults Patients After Discharged From Heart Failure Hospitalization Registry record

    Expected 2024-03-01; that period ended on 2024-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06018532

  30. Study start The Exploratory Study About the Effect of Using Double Filtration Plasmapheresis (DFPP) Removing Inflammatory Cytokines, Lipids and Toxic Metal Ions in Peripheral Blood in Adults Registry record

    Expected 2024-03-01; that period ended on 2024-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06224296

  31. Study start Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER) Registry record

    Expected 2024-03-01; that period ended on 2024-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06227286

  32. Study start Assessment of Therapeutic Effect of Rectal Vs. Intravenous Paracetamol in The Treatment of Patent Ductus Arteriosus (PDA) in Neonates Registry record

    Expected 2024-03-01; that period ended on 2024-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06256211

  33. Study start Topical Nitro or Placebo Pre-Cath Registry record

    Expected 2024-03-01; that period ended on 2024-03-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06289946

  34. Study completion Fluoroscopy Reduction or Elimination in CIED Implants Registry record

    Expected 2024-03-03; that period ended on 2024-03-03.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04919733

  35. Study start Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins Registry record

    Expected 2024-03-04; that period ended on 2024-03-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06262685

  36. Study completion Thrombolysis Combined With Edaravone Dexborneol on Hemorrhagic Transformation for Acute Ischemic Stroke Registry record

    Expected 2024-03-13; that period ended on 2024-03-13.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05035953

  37. Study completion Early Hydrogen-Oxygen Gas Mixture Inhalation in Patients With Aneurysmal Subarachnoid Hemorrhage (HOMA) Registry record

    Expected 2024-03-15; that period ended on 2024-03-15.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05282836

  38. Study start Tongyuan Acupuncture on Consciousness Disorder After Stroke Registry record

    Expected 2024-03-20; that period ended on 2024-03-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06202833

  39. Study start Effectiveness and Safety of Coronary Scoring Balloon Dilation Catheter in the Pretreatment of Coronary Stenosis Lesions Registry record

    Expected 2024-03-20; that period ended on 2024-03-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06291545

  40. Study completion Modulation of Cortical Gamma Synchrony in Stroke Registry record

    Expected 2024-03-23; that period ended on 2024-03-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05830617

  41. Primary completion Modulation of Cortical Gamma Synchrony in Stroke Registry record

    Expected 2024-03-23; that period ended on 2024-03-23.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05830617

  42. Study start Timely Recovery After Subclinical Heart Failure Registry record

    Expected 2024-03-26; that period ended on 2024-03-26.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06341101

  43. Study completion Using AR Dental Care Training System in HE on Periodontal Status, Blood Sugar Control and QoL in Patients With T2DM Registry record

    Expected 2024-03-27; that period ended on 2024-03-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05941468

  44. Primary completion Using AR Dental Care Training System in HE on Periodontal Status, Blood Sugar Control and QoL in Patients With T2DM Registry record

    Expected 2024-03-27; that period ended on 2024-03-27.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05941468

  45. Study completion Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD Registry record

    Expected 2024-03-29; that period ended on 2024-03-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05580510

  46. Study completion Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients (3T Stroke-Ⅲ) Registry record

    Expected 2024-03-29; that period ended on 2024-03-29.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05745259

  47. Primary completion Head-of-Bed Positioning in Large Artery Acute Ischemic Stroke Registry record

    Expected 2024-03-30; that period ended on 2024-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05073159

  48. Study completion A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes Registry record

    Expected 2024-03-30; that period ended on 2024-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05333835

  49. Primary completion A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes Registry record

    Expected 2024-03-30; that period ended on 2024-03-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05333835

  50. Study completion Open-label Study of Neuraminidase Inhibitor Treatment in STEMI Patients Registry record

    Expected 2024-03-31; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04684498

  51. Study completion A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes Registry record

    Expected 2024-03; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05063253

  52. Primary completion A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes Registry record

    Expected 2024-03; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05063253

  53. Study completion Continuous Ambulatory Cardiac Monitoring for Recurrent Atrial Fibrillation After Sepsis Registry record

    Expected 2024-03; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05217485

  54. Primary completion Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease Registry record

    Expected 2024-03; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05373004

  55. Study completion The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes Registry record

    Expected 2024-03-31; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05386186

  56. Primary completion Clinical Trial for GNX80 in Intermittent Claudication Registry record

    Expected 2024-03; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05400395

  57. Study completion Safety Study of Intracranial Support Catheter and Guide Catheter for Stent-Assisted Embolization in the Treatment of Intracranial Aneurysms Registry record

    Expected 2024-03; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05524285

  58. Study completion CerebrAlcare Pills on CereBral Small VesseL DiseasE(CABLE) Registry record

    Expected 2024-03-31; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05578521

  59. Primary completion The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment Registry record

    Expected 2024-03-31; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05803759

  60. Study start A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus Registry record

    Expected 2024-03; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06140485

  61. Study start NW Roselle in Grade 1 Essential Hypertension: Phase III Clinical Trial Registry record

    Expected 2024-03; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06141200

  62. Study start Oral Enteral Nutrition Tube Feeding on Stroke Survivors Registry record

    Expected 2024-03; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06301646

  63. Study start The Impact of Different Feeding Modes on Patients With Intracerebral Hemorrhage Registry record

    Expected 2024-03; that period ended on 2024-03-31.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06328946

  64. Primary completion HANGZHOU Solution in Bicuspid AS Undergoing TAVR Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04722796

  65. Study completion Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05241431

  66. Study completion Low-dose PCSK9 Inhibitor Combined With Stains on Serum Lipids in Chinese Population With Acute Coronary Syndrome Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05298475

  67. Primary completion High-Resolution Assessment of Extracranial Plaques in a Multiple Centers Evolocumab Randomized Study Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05585151

  68. Primary completion Follow up of Clinical Outcome of Deferred vs Immediate Stenting in High Thrombus Stemi Patients Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05793671

  69. Primary completion The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole) Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05820048

  70. Study start Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06013020

  71. Study completion Alio WEAR Study: Long-term Wear of the Alio Platform Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06056739

  72. Primary completion Alio WEAR Study: Long-term Wear of the Alio Platform Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06056739

  73. Study start MAgnetic Resonance Imaging-guided implanTation of Cardioverter DEFibrillators Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06269692

  74. Study start CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06283888

  75. Study start Phitys I™ Percutaneous Left Ventricular Assist System Study Registry record

    Expected 2024-04-01; that period ended on 2024-04-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06357026

  76. Primary completion Optical Coherence Tomography of the Saphenous Vein Graft Registry record

    Expected 2024-04-04; that period ended on 2024-04-04.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05129228

  77. Study completion DENEX, Renal Denervation Therapy, in Patients With Hypertension on no or 1-3 Antihypertensive Medications Registry record

    Expected 2024-04-17; that period ended on 2024-04-17.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04307836

  78. Study start Study on the Efficacy of Alprostadil Injection in Patients With Acute Ischemic Stroke Registry record

    Expected 2024-04-18; that period ended on 2024-04-18.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03252626

  79. Study completion Registry to Evaluate Chinese Real-World Clinical Outcomes in Patients With AF Using the WATCHMAN Left Atrial Appendage Closure Technology Registry record

    Expected 2024-04-20; that period ended on 2024-04-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03917563

  80. Study completion Uninterrupted Direct-acting Oral Anticoagulation in Patients Undergoing Transradial Percutaneous Coronary Procedures Registry record

    Expected 2024-04-20; that period ended on 2024-04-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05292846

  81. Primary completion The Effects of Allicor on Patients After Revascularization Treatment During a Year Registry record

    Expected 2024-04-20; that period ended on 2024-04-20.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05813171

  82. Primary completion The POST-ACS Study Registry record

    Expected 2024-04-28; that period ended on 2024-04-28.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05322200

  83. Study completion Biolimus A9™ (BA9™) Drug Coated Balloon (DCB) Study Registry record

    Expected 2024-04; that period ended on 2024-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04079192

  84. Primary completion Left Atrial Posterior Wall and PV Isolation Using Cryoballoon for Treatment of Persistent AF Registry record

    Expected 2024-04-30; that period ended on 2024-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04505163

  85. Study completion Empagliflozin and Atrial Fibrillation Treatment Registry record

    Expected 2024-04; that period ended on 2024-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04583813

  86. Primary completion IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease Registry record

    Expected 2024-04; that period ended on 2024-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT04849325

  87. Study completion Head-of-Bed Positioning in Large Artery Acute Ischemic Stroke Registry record

    Expected 2024-04-30; that period ended on 2024-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05073159

  88. Primary completion ThrombX Retriever for Acute Ischemic Stroke Trial Registry record

    Expected 2024-04; that period ended on 2024-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05270122

  89. Study completion FreeStyle Libre 2 Discharge Trial Registry record

    Expected 2024-04-30; that period ended on 2024-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05822232

  90. Primary completion FreeStyle Libre 2 Discharge Trial Registry record

    Expected 2024-04-30; that period ended on 2024-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05822232

  91. Study start Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER) Registry record

    Expected 2024-04; that period ended on 2024-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05976152

  92. Study start Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes Registry record

    Expected 2024-04; that period ended on 2024-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06339086

  93. Study start The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes Registry record

    Expected 2024-04-30; that period ended on 2024-04-30.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT06408532

  94. Study completion Metformin Therapy in Non-diabetic AAA Patients Registry record

    Expected 2024-05-01; that period ended on 2024-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03507413

  95. Primary completion Metformin Therapy in Non-diabetic AAA Patients Registry record

    Expected 2024-05-01; that period ended on 2024-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT03507413

  96. Primary completion Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial Registry record

    Expected 2024-05-01; that period ended on 2024-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05309460

  97. Study completion Cryoablation With Vestibular Expansion for the Treatment of Paroxysmal/Short-course Persistent Atrial Fibrillation Registry record

    Expected 2024-05-01; that period ended on 2024-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05311098

  98. Study completion Clinical Trial in China Registry record

    Expected 2024-05-01; that period ended on 2024-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05580952

  99. Primary completion rTMS in Chronic Poststroke Dysphagia Registry record

    Expected 2024-05-01; that period ended on 2024-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05590819

  100. Study start Concomitant Tricuspid Repair in Patients With Left Heart Surgery Registry record

    Expected 2024-05-01; that period ended on 2024-05-01.

    Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on .

    Source: ClinicalTrials.gov record NCT05595187